Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hussain R. Yusuf is active.

Publication


Featured researches published by Hussain R. Yusuf.


American Journal of Preventive Medicine | 2000

Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults

Peter A. Briss; Lance E. Rodewald; Alan R. Hinman; Abigail Shefer; Raymond A. Strikas; Roger R. Bernier; Vilma G Carande-Kulis; Hussain R. Yusuf; Serigne M. Ndiaye; Sheree M. Williams

Abstract Background: This paper presents the results of systematic reviews of the effectiveness, applicability, other effects, economic impact, and barriers to use of selected population-based interventions intended to improve vaccination coverage. The related systematic reviews are linked by a common conceptual approach. These reviews form the basis for recommendations by the Task Force on Community Preventive Services (the Task Force) regarding the use of these selected interventions. The Task Force recommendations are presented on pp. 92–96 of this issue.


American Journal of Preventive Medicine | 2000

Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults 1 2

Peter A. Briss; Lance E. Rodewald; Alan R. Hinman; Abigail Shefer; Raymond A. Strikas; Roger R. Bernier; Vilma G Carande-Kulis; Hussain R. Yusuf; Serigne M. Ndiaye; Sheree M. Williams

Abstract Background: This paper presents the results of systematic reviews of the effectiveness, applicability, other effects, economic impact, and barriers to use of selected population-based interventions intended to improve vaccination coverage. The related systematic reviews are linked by a common conceptual approach. These reviews form the basis for recommendations by the Task Force on Community Preventive Services (the Task Force) regarding the use of these selected interventions. The Task Force recommendations are presented on pp. 92–96 of this issue.


American Journal of Preventive Medicine | 2010

Emergency Department Visits Made by Patients with Sickle Cell Disease: A Descriptive Study, 1999–2007

Hussain R. Yusuf; Hani K. Atrash; Scott D. Grosse; Christopher S. Parker; Althea M. Grant

BACKGROUND Patients with sickle cell disease (SCD) often use emergency department services to obtain medical care. Limited information is available about emergency department use among patients with SCD. PURPOSE This study assessed characteristics of emergency department visits made nationally by patients with SCD. METHODS Data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) for the years 1999-2007 were analyzed. The NHAMCS is a survey of hospital emergency department and outpatient visits. Emergency department visits by patients with SCD were identified using ICD-9-CM codes, and nationally weighted estimates were calculated. RESULTS On average, approximately 197,333 emergency department visits were estimated to have occurred each year between 1999 and 2007 with SCD as one of the diagnoses listed. The expected source of payment was private insurance for 14%, Medicaid/State Childrens Health Insurance Program for 58%, Medicare for 14%, and other/unknown for 15%. Approximately 29% of visits resulted in hospital admission; this was 37% among patients aged 0-19 years, and 26% among patients aged >/=20 years. The episode of care was indicated as a follow-up visit for 23% of the visits. Patient-cited reasons for the emergency department visit included chest pain (11%); other pain or unspecified pain (67%); fever/infection (6%); and shortness of breath/breathing problem/cough (5%), among other reasons. CONCLUSIONS Substantial numbers of emergency department visits occur among people with SCD. The most common reason for the emergency department visits is pain symptoms. The findings of this study can help to improve health services delivery and utilization among patients with SCD.


The Journal of Infectious Diseases | 2004

An Economic Analysis of the Current Universal 2-dose measles-mumps-rubella Vaccination Program in the United States

Fangjun Zhou; Susan E. Reef; Mehran S. Massoudi; Mark J. Papania; Hussain R. Yusuf; Barbara Bardenheier; Laura Zimmerman; Mary Mason McCauley

To evaluate the economic impact of the current 2-dose measles-mumps-rubella (MMR) vaccination program in the United States, a decision tree-based analysis was conducted with population-based vaccination coverage and disease incidence data. All costs were estimated for a hypothetical US birth cohort of 3803295 infants born in 2001. The 2-dose MMR vaccination program was cost-saving from both the direct cost and societal perspectives compared with the absence of MMR vaccination, with net savings (net present value) from the direct cost and societal perspectives of US dollars 3.5 billion and US dollars 7.6 billion, respectively. The direct and societal benefit-cost ratios for the MMR vaccination program were 14.2 and 26.0. Analysis of the incremental benefit-cost of the second dose showed that direct and societal benefit-cost ratios were 0.31 and 0.49, respectively. Varying the proportion of vaccines purchased and administered in the public versus the private sector had little effect on the results. From both perspectives under even the most conservative assumptions, the national 2-dose MMR vaccination program is highly cost-beneficial and results in substantial cost savings.


The Lancet | 2000

Injury-related deaths among women aged 10-50 years in Bangladesh, 1996-97

Hussain R. Yusuf; Halida H. Akhter; M. Hafizur Rahman; Mahbub Elahi Chowdhury; Roger W. Rochat

BACKGROUND Few studies have examined injury-related deaths among women in Bangladesh. We did a case-finding study to identify causes and the impact of intentional and unintentional injury-related deaths among women aged 10-50 years in Bangladesh. METHODS Between 1996 and 1997, health care and other service providers at 4751 health facilities throughout Bangladesh were interviewed about their knowledge of deaths among women aged 10-50 years. In addition, at all public facilities providing inpatient service, medical records of women who died during the study period were reviewed. The reported circumstances surrounding each death were carefully reviewed to attribute the most likely cause of death. FINDINGS 28,998 deaths among women aged 10-50 years were identified in our study, and, of these, 6610 (23%) were thought to be caused by intentional or unintentional injuries. About half (3317) of the injury deaths were attributable to suicide, 352 (5%) to homicide, 1100 (17%) to accidental injuries, and the intent was unknown for 1841 (28%) deaths. The unadjusted rate of suicides were higher in the Khulna administrative division (27.0 per 100,000) than the other four administrative divisions of Bangladesh (range 3.5-11.3 per 100,000). Poisoning (n=3971) was the commonest cause of injury-related death--60% of all injury deaths (6610) and 14% of all deaths (28,998). Other common causes of injury deaths in order of frequency were hanging or suffocation, road traffic accidents, burns, drowning, physical assault, firearm or sharp instrument injury, and snake or animal bite. INTERPRETATION Intentional and unintentional injuries are a major cause of death among women aged 10-50 years in Bangladesh. Strategies to reduce injury-related deaths among women need to be devised.


Public Health Reports | 2004

Factors Associated with Underimmunization at 3 Months of Age in Four Medically Underserved Areas

Barbara Bardenheier; Hussain R. Yusuf; Jorge Rosenthal; Jeanne M. Santoli; Abigail Shefer; Donna Rickert; Susan Y. Chu

Objective. Risk factors for underimmunization at 3 months of age are not well described. This study examines coverage rates and factors associated with underimmunization at 3 months of age in four medically underserved areas. Methods. During 1997–1998, cross-sectional household surveys using a two-stage cluster sample design were conducted in four federally designated Health Professional Shortage Areas. Respondents were parents or caregivers of children ages 12–35 months: 847 from northern Manhattan, 843 from Detroit, 771 from San Diego, and 1,091 from rural Colorado. A child was considered up-to-date (UTD) with vaccinations at 3 months of age if documentation of receipt of diphtheria-tetanus-pertussis, polio, haemophilus influenzae type B, and hepatitis B vaccines was obtained from a provider or a hand-held vaccination card, or both. Results. Household response rates ranged from 79% to 88% across sites. Vaccination coverage levels at 3 months of age varied across sites: 82.4% in northern Manhattan, 70.5% in Detroit, 82.3% in San Diego, and 75.8% in rural Colorado. Among children who were not UTD, the majority (65.7% to 71.5% per site) had missed vaccines due to missed opportunities. Factors associated with not being UTD varied by site and included having public or no insurance, ⩾2 children living in the household, and the adult respondent being unmarried. At all sites, vaccination coverage among WIC enrollees was higher than coverage among children eligible for but not enrolled in WIC, but the association between UTD status and WIC enrollment was statistically significant for only one site and marginally significant for two other sites. Conclusions. Missed opportunities were a significant barrier to vaccinations, even at this early age. Practice-based strategies to reduce missed opportunities and prenatal WIC enrollment should be focused especially toward those at highest risk of underimmunization.


Thrombosis Research | 2015

Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees☆

Hussain R. Yusuf; W. Craig Hooper; Scott D. Grosse; Christopher S. Parker; Sheree L. Boulet; Thomas L. Ortel

OBJECTIVE This study assessed the risk of venous thromboembolism (VTE) among privately insured adults in the U.S. with one or more of the following autoimmune diseases: autoimmune hemolytic anemia (AIHA), immune thrombocytopenic purpura (ITP), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). MATERIALS AND METHODS Using the Truven Health MarketScan® Databases, patients 18-64 years of age with a diagnosis of AIHA, ITP, RA, or SLE in 2007 and a sex and age-group matched comparison group of enrollees were followed up through 2010 to identify VTE events. Survival curve and Cox proportional hazards analyses were conducted to assess differences between groups. RESULTS Among patients with AIHA, ITP, RA, or SLE, or >1 of these diseases, the risk of at least one VTE event was 19.74, 7.72, 4.90, 9.89, and 13.35 per 1,000 person-years, respectively; among the comparison group, the risk was 1.91 per 1,000 person-years. The adjusted hazard ratios (aHRs) for VTE among patients with AIHA, ITP, RA, or SLE, or >1 of these diseases (when compared with the comparison group) tended to decline over follow-up time; at 1year, the aHRs were 6.30 (95% confidence interval [CI]: 4.44-8.94), 2.95 (95% CI: 2.18-4.00), 2.13 (95% CI: 1.89-2.40), 4.68 (95% CI: 4.10-5.33), and 5.11 (95% CI: 4.26-6.14), respectively. CONCLUSION Having AIHA, ITP, RA, or SLE, or >1 of these diseases was associated with an increased likelihood of a VTE event. More research is necessary to develop better understanding of VTE occurrence among people with autoimmune diseases.


American Journal of Obstetrics and Gynecology | 2012

Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003–2008

Ekwutosi M. Okoroh; W. Craig Hooper; Hani K. Atrash; Hussain R. Yusuf; Sheree L. Boulet

OBJECTIVE We sought to determine prevalence and likelihood of venous thromboembolism (VTE) among women with and without polycystic ovary syndrome (PCOS). STUDY DESIGN We performed a cross-sectional analysis using Thomson Reuters MarketScan Commercial databases for the years 2003 through 2008. The association between VTE and PCOS among women aged 18-45 years was assessed using age-stratified multivariable logistic regression models. RESULTS Prevalence of VTE per 100,000 was 374.2 for PCOS women and 193.8 for women without PCOS. Compared with women without PCOS, those with PCOS were more likely to have VTE (adjusted odds ratio [aOR] 18-24 years, 3.26; 95% confidence interval [CI], 2.61-4.08; aOR 25-34 years, 2.39; 95% CI, 2.12-2.70; aOR 35-45 years, 2.05; 95% CI, 1.84-2.38). A protective association (odds ratio, 0.8; 95% CI, 0.73-0.98) with oral contraceptive use was noted for PCOS women. CONCLUSION PCOS might be a predisposing condition for VTE, particularly among women aged 18-24 years. Oral contraceptive use might be protective.


Public Health Reports | 2004

Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000

Kieran J. Fogarty; Mehran S. Massoudi; William Gallo; Francisco Averhoff; Hussain R. Yusuf; Daniel B. Fishbein

Objective. Little information is available about the effectiveness of school entry vaccination requirements at the middle school level. This study examined coverage levels among students entering seventh grade in Florida following implementation of a school entry vaccination requirement in 1997. Methods. The authors analyzed county-specific vaccination coverage levels (three doses of hepatitis B vaccine, a second dose of measles, mumps, and rubella [MMR] vaccine, and a booster dose of tetanus and diphtheria toxoids [Td]) among students entering public and private schools in Florida from 1997 through 2000. In 1998, a survey of all county health departments was conducted, and the resulting data were linked to county-specific vaccination rates. Results. During the 1997–1998 school year, the first year the requirement went into effect, at school entry 121,219 seventh-grade students (61.8%) were fully vaccinated, 72,275 seventh grade students (36.9%) lacked one or more doses of vaccine but were considered in process, 1,817 were non-compliant (0.9%), and 763 had medical or religious exemptions (0.4%). In the 2000–2001 school year, the proportions of students reported fully vaccinated at school entry had increased to 66%. Most of this change was related to an increase in hepatitis B coverage. There was a significant inverse relationship between the proportion of students fully vaccinated and the size of the countys seventh grade population. Conclusions. The seventh grade vaccination entry requirement was associated with sustained high levels of vaccination coverage. Passing a school entry vaccination requirement appears may be sufficient to increase coverage, but other strategies may be required to achieve full immunization of middle school students.


Pediatrics | 2012

Trends in venous thromboembolism-related hospitalizations, 1994-2009.

Sheree L. Boulet; Scott D. Grosse; Courtney D. Thornburg; Hussain R. Yusuf; James Tsai; W. Craig Hooper

OBJECTIVE: Information on trends in venous thromboembolism (VTE) in US children is scant and inconsistent. We assessed national trends in VTE-associated pediatric hospitalizations. METHODS: All nonroutine newborn hospitalizations for children 0 to 17 years of age in the 1994–2009 Nationwide Inpatient Samples were included; routine newborn discharges were excluded. VTE diagnoses were identified by using the International Classification of Diseases, Ninth Revision, Clinical Modification codes. Variance weighted least square regression was used to assess trends in patient characteristics and rates of hospitalization per 100 000 population <18 years of age. Multivariable logistic regression models were used to estimate the probability of VTE diagnosis over the study period. RESULTS: The rate of VTE-associated hospitalization increased for all age subgroups (<1, 1–5, 6–11, and 12–17 years), with the largest increase noted among children <1 year of age (from 18.1 per 100 000 during 1994 to 49.6 per 100 000 during 2009). Compared with 1994–1997, the adjusted odds of hospitalization with a VTE diagnosis were 88% higher during 2006–2009 (adjusted odds ratio: 1.88 [95% confidence interval: 1.64–2.17]). Venous catheter use, mechanical ventilation, malignancy, hospitalization ≥5 days, and VTE-related medical conditions were associated with increased likelihood of VTE diagnosis. CONCLUSIONS: The rate of VTE-associated hospitalization among US children increased from 1994 through 2009. Increases in venous catheter procedures were associated with and may have contributed to the observed trends. The degree to which increased awareness of VTE influenced the temporal differences could not be determined.

Collaboration


Dive into the Hussain R. Yusuf's collaboration.

Top Co-Authors

Avatar

Lance E. Rodewald

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Abigail Shefer

National Center for Immunization and Respiratory Diseases

View shared research outputs
Top Co-Authors

Avatar

Susan Y. Chu

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Hani K. Atrash

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Mehran S. Massoudi

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sheree L. Boulet

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Danni Daniels

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

James Tsai

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Peter A. Briss

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge